Drug Profile


Alternative Names: AV2-DM

Latest Information Update: 13 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cesa Projects International
  • Class Antivirals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Human papillomavirus infections

Most Recent Events

  • 13 Aug 2015 No recent reports on development identified - Phase-II for Human papillomavirus infections in Belgium (Topical)
  • 08 Nov 2012 Cesa Projects International completes enrolment in its phase II trial for Human papillomavirus infections in Belgium (NCT01654822)
  • 01 Aug 2012 Phase-II clinical trials in Human papillomavirus infections in Belgium (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top